Cargando…
Epigenetic regulation during cancer transitions across 11 tumour types
Chromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis(1–4). Although the genetic contributions to oncogenic transitions have been investigated, epigeneti...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632147/ https://www.ncbi.nlm.nih.gov/pubmed/37914932 http://dx.doi.org/10.1038/s41586-023-06682-5 |
_version_ | 1785132516275912704 |
---|---|
author | Terekhanova, Nadezhda V. Karpova, Alla Liang, Wen-Wei Strzalkowski, Alexander Chen, Siqi Li, Yize Southard-Smith, Austin N. Iglesia, Michael D. Wendl, Michael C. Jayasinghe, Reyka G. Liu, Jingxian Song, Yizhe Cao, Song Houston, Andrew Liu, Xiuting Wyczalkowski, Matthew A. Lu, Rita Jui-Hsien Caravan, Wagma Shinkle, Andrew Naser Al Deen, Nataly Herndon, John M. Mudd, Jacqueline Ma, Cong Sarkar, Hirak Sato, Kazuhito Ibrahim, Omar M. Mo, Chia-Kuei Chasnoff, Sara E. Porta-Pardo, Eduard Held, Jason M. Pachynski, Russell Schwarz, Julie K. Gillanders, William E. Kim, Albert H. Vij, Ravi DiPersio, John F. Puram, Sidharth V. Chheda, Milan G. Fuh, Katherine C. DeNardo, David G. Fields, Ryan C. Chen, Feng Raphael, Benjamin J. Ding, Li |
author_facet | Terekhanova, Nadezhda V. Karpova, Alla Liang, Wen-Wei Strzalkowski, Alexander Chen, Siqi Li, Yize Southard-Smith, Austin N. Iglesia, Michael D. Wendl, Michael C. Jayasinghe, Reyka G. Liu, Jingxian Song, Yizhe Cao, Song Houston, Andrew Liu, Xiuting Wyczalkowski, Matthew A. Lu, Rita Jui-Hsien Caravan, Wagma Shinkle, Andrew Naser Al Deen, Nataly Herndon, John M. Mudd, Jacqueline Ma, Cong Sarkar, Hirak Sato, Kazuhito Ibrahim, Omar M. Mo, Chia-Kuei Chasnoff, Sara E. Porta-Pardo, Eduard Held, Jason M. Pachynski, Russell Schwarz, Julie K. Gillanders, William E. Kim, Albert H. Vij, Ravi DiPersio, John F. Puram, Sidharth V. Chheda, Milan G. Fuh, Katherine C. DeNardo, David G. Fields, Ryan C. Chen, Feng Raphael, Benjamin J. Ding, Li |
author_sort | Terekhanova, Nadezhda V. |
collection | PubMed |
description | Chromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis(1–4). Although the genetic contributions to oncogenic transitions have been investigated, epigenetic drivers remain less understood. Here we constructed a pan-cancer epigenetic and transcriptomic atlas using single-nucleus chromatin accessibility data (using single-nucleus assay for transposase-accessible chromatin) from 225 samples and matched single-cell or single-nucleus RNA-sequencing expression data from 206 samples. With over 1 million cells from each platform analysed through the enrichment of accessible chromatin regions, transcription factor motifs and regulons, we identified epigenetic drivers associated with cancer transitions. Some epigenetic drivers appeared in multiple cancers (for example, regulatory regions of ABCC1 and VEGFA; GATA6 and FOX-family motifs), whereas others were cancer specific (for example, regulatory regions of FGF19, ASAP2 and EN1, and the PBX3 motif). Among epigenetically altered pathways, TP53, hypoxia and TNF signalling were linked to cancer initiation, whereas oestrogen response, epithelial–mesenchymal transition and apical junction were tied to metastatic transition. Furthermore, we revealed a marked correlation between enhancer accessibility and gene expression and uncovered cooperation between epigenetic and genetic drivers. This atlas provides a foundation for further investigation of epigenetic dynamics in cancer transitions. |
format | Online Article Text |
id | pubmed-10632147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106321472023-11-10 Epigenetic regulation during cancer transitions across 11 tumour types Terekhanova, Nadezhda V. Karpova, Alla Liang, Wen-Wei Strzalkowski, Alexander Chen, Siqi Li, Yize Southard-Smith, Austin N. Iglesia, Michael D. Wendl, Michael C. Jayasinghe, Reyka G. Liu, Jingxian Song, Yizhe Cao, Song Houston, Andrew Liu, Xiuting Wyczalkowski, Matthew A. Lu, Rita Jui-Hsien Caravan, Wagma Shinkle, Andrew Naser Al Deen, Nataly Herndon, John M. Mudd, Jacqueline Ma, Cong Sarkar, Hirak Sato, Kazuhito Ibrahim, Omar M. Mo, Chia-Kuei Chasnoff, Sara E. Porta-Pardo, Eduard Held, Jason M. Pachynski, Russell Schwarz, Julie K. Gillanders, William E. Kim, Albert H. Vij, Ravi DiPersio, John F. Puram, Sidharth V. Chheda, Milan G. Fuh, Katherine C. DeNardo, David G. Fields, Ryan C. Chen, Feng Raphael, Benjamin J. Ding, Li Nature Article Chromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis(1–4). Although the genetic contributions to oncogenic transitions have been investigated, epigenetic drivers remain less understood. Here we constructed a pan-cancer epigenetic and transcriptomic atlas using single-nucleus chromatin accessibility data (using single-nucleus assay for transposase-accessible chromatin) from 225 samples and matched single-cell or single-nucleus RNA-sequencing expression data from 206 samples. With over 1 million cells from each platform analysed through the enrichment of accessible chromatin regions, transcription factor motifs and regulons, we identified epigenetic drivers associated with cancer transitions. Some epigenetic drivers appeared in multiple cancers (for example, regulatory regions of ABCC1 and VEGFA; GATA6 and FOX-family motifs), whereas others were cancer specific (for example, regulatory regions of FGF19, ASAP2 and EN1, and the PBX3 motif). Among epigenetically altered pathways, TP53, hypoxia and TNF signalling were linked to cancer initiation, whereas oestrogen response, epithelial–mesenchymal transition and apical junction were tied to metastatic transition. Furthermore, we revealed a marked correlation between enhancer accessibility and gene expression and uncovered cooperation between epigenetic and genetic drivers. This atlas provides a foundation for further investigation of epigenetic dynamics in cancer transitions. Nature Publishing Group UK 2023-11-01 2023 /pmc/articles/PMC10632147/ /pubmed/37914932 http://dx.doi.org/10.1038/s41586-023-06682-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Terekhanova, Nadezhda V. Karpova, Alla Liang, Wen-Wei Strzalkowski, Alexander Chen, Siqi Li, Yize Southard-Smith, Austin N. Iglesia, Michael D. Wendl, Michael C. Jayasinghe, Reyka G. Liu, Jingxian Song, Yizhe Cao, Song Houston, Andrew Liu, Xiuting Wyczalkowski, Matthew A. Lu, Rita Jui-Hsien Caravan, Wagma Shinkle, Andrew Naser Al Deen, Nataly Herndon, John M. Mudd, Jacqueline Ma, Cong Sarkar, Hirak Sato, Kazuhito Ibrahim, Omar M. Mo, Chia-Kuei Chasnoff, Sara E. Porta-Pardo, Eduard Held, Jason M. Pachynski, Russell Schwarz, Julie K. Gillanders, William E. Kim, Albert H. Vij, Ravi DiPersio, John F. Puram, Sidharth V. Chheda, Milan G. Fuh, Katherine C. DeNardo, David G. Fields, Ryan C. Chen, Feng Raphael, Benjamin J. Ding, Li Epigenetic regulation during cancer transitions across 11 tumour types |
title | Epigenetic regulation during cancer transitions across 11 tumour types |
title_full | Epigenetic regulation during cancer transitions across 11 tumour types |
title_fullStr | Epigenetic regulation during cancer transitions across 11 tumour types |
title_full_unstemmed | Epigenetic regulation during cancer transitions across 11 tumour types |
title_short | Epigenetic regulation during cancer transitions across 11 tumour types |
title_sort | epigenetic regulation during cancer transitions across 11 tumour types |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632147/ https://www.ncbi.nlm.nih.gov/pubmed/37914932 http://dx.doi.org/10.1038/s41586-023-06682-5 |
work_keys_str_mv | AT terekhanovanadezhdav epigeneticregulationduringcancertransitionsacross11tumourtypes AT karpovaalla epigeneticregulationduringcancertransitionsacross11tumourtypes AT liangwenwei epigeneticregulationduringcancertransitionsacross11tumourtypes AT strzalkowskialexander epigeneticregulationduringcancertransitionsacross11tumourtypes AT chensiqi epigeneticregulationduringcancertransitionsacross11tumourtypes AT liyize epigeneticregulationduringcancertransitionsacross11tumourtypes AT southardsmithaustinn epigeneticregulationduringcancertransitionsacross11tumourtypes AT iglesiamichaeld epigeneticregulationduringcancertransitionsacross11tumourtypes AT wendlmichaelc epigeneticregulationduringcancertransitionsacross11tumourtypes AT jayasinghereykag epigeneticregulationduringcancertransitionsacross11tumourtypes AT liujingxian epigeneticregulationduringcancertransitionsacross11tumourtypes AT songyizhe epigeneticregulationduringcancertransitionsacross11tumourtypes AT caosong epigeneticregulationduringcancertransitionsacross11tumourtypes AT houstonandrew epigeneticregulationduringcancertransitionsacross11tumourtypes AT liuxiuting epigeneticregulationduringcancertransitionsacross11tumourtypes AT wyczalkowskimatthewa epigeneticregulationduringcancertransitionsacross11tumourtypes AT luritajuihsien epigeneticregulationduringcancertransitionsacross11tumourtypes AT caravanwagma epigeneticregulationduringcancertransitionsacross11tumourtypes AT shinkleandrew epigeneticregulationduringcancertransitionsacross11tumourtypes AT naseraldeennataly epigeneticregulationduringcancertransitionsacross11tumourtypes AT herndonjohnm epigeneticregulationduringcancertransitionsacross11tumourtypes AT muddjacqueline epigeneticregulationduringcancertransitionsacross11tumourtypes AT macong epigeneticregulationduringcancertransitionsacross11tumourtypes AT sarkarhirak epigeneticregulationduringcancertransitionsacross11tumourtypes AT satokazuhito epigeneticregulationduringcancertransitionsacross11tumourtypes AT ibrahimomarm epigeneticregulationduringcancertransitionsacross11tumourtypes AT mochiakuei epigeneticregulationduringcancertransitionsacross11tumourtypes AT chasnoffsarae epigeneticregulationduringcancertransitionsacross11tumourtypes AT portapardoeduard epigeneticregulationduringcancertransitionsacross11tumourtypes AT heldjasonm epigeneticregulationduringcancertransitionsacross11tumourtypes AT pachynskirussell epigeneticregulationduringcancertransitionsacross11tumourtypes AT schwarzjuliek epigeneticregulationduringcancertransitionsacross11tumourtypes AT gillanderswilliame epigeneticregulationduringcancertransitionsacross11tumourtypes AT kimalberth epigeneticregulationduringcancertransitionsacross11tumourtypes AT vijravi epigeneticregulationduringcancertransitionsacross11tumourtypes AT dipersiojohnf epigeneticregulationduringcancertransitionsacross11tumourtypes AT puramsidharthv epigeneticregulationduringcancertransitionsacross11tumourtypes AT chhedamilang epigeneticregulationduringcancertransitionsacross11tumourtypes AT fuhkatherinec epigeneticregulationduringcancertransitionsacross11tumourtypes AT denardodavidg epigeneticregulationduringcancertransitionsacross11tumourtypes AT fieldsryanc epigeneticregulationduringcancertransitionsacross11tumourtypes AT chenfeng epigeneticregulationduringcancertransitionsacross11tumourtypes AT raphaelbenjaminj epigeneticregulationduringcancertransitionsacross11tumourtypes AT dingli epigeneticregulationduringcancertransitionsacross11tumourtypes |